A Prospective Economic Analysis of Early Outcome Data From the Alliance A041202/ CCTG CLC.2 Randomized Phase III Trial Of Bendamustine-Rituximab Compared With Ibrutinib-Based Regimens in Untreated Older Patients With Chronic Lymphocytic Leukemia

Autor: Cheung, Matthew C. 1, 2, ⁎, Mittmann, Nicole 2, 3, Owen, Carolyn 4, Abdel-Samad, Nizar 5, Fraser, Graeme A.M. 6, Lam, Selay 7, Crump, Michael 2, 8, Sperlich, Catherine 9, van der Jagt, Richard 10, Prica, Anca 2, 8, Couban, Stephen 2, 11, Woyach, Jennifer A. 12, Ruppert, Amy S. 12, 13, Booth, Allison M. 13, 14, Mandrekar, Sumithra J. 14, McDonald, Gail 2, Shepherd, Lois E. 3, Yen, Hope 2, Chen, Bingshu E. 2, Hay, Annette E. 2, 15
Zdroj: In Clinical Lymphoma, Myeloma and Leukemia November 2021 21(11):766-774
Databáze: ScienceDirect
Externí odkaz: